VIATRIS INC. for VIATRIS INC
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Global Health Appropriations, President's Emergency Plan for AIDS Relief funding, Global Fund funding, FY2014 Budget, FY 2015 Budget, FY2015 Appropriations, Funding for FDA, Funding for the Office of Generic Drugs, Generic Drug User Fees, Biosimilar User Fees
| Lobbyist | Covered position, as disclosed |
|---|---|
| NIMISH SHAH | — |
| KIMBERLEE TRZECIAK | — |
Taxation/Internal Revenue Code TAX
Tax Reform, Tax Extenders
| Lobbyist | Covered position, as disclosed |
|---|---|
| NIMISH SHAH | — |
Copyright/Patent/Trademark CPT
Patent Settlements, Patent Reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| NIMISH SHAH | — |
Health Issues HCR
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 3204, the Drug Quality and Security Act; Compounding; Generic Labeling; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, the Preserve Access to Affordable Generics; S. 504, the Fair and Immediate Release of Generic Drugs Act; H.R. 2725, the FDA Safety Over Sequestration Act of 2013; S. 621, the Safe Prescribing Act of 2013Risk Evaluation Mitigation Strategies; H.R. 460, Patients' Access to Treatments Act of 2013; implementation of the Generic Drug User Fee Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| NIMISH SHAH | — |
| KIMBERLEE TRZECIAK | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.